Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.44 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10296001 | 0.87 | ALDH1A1 (0.55) | CYP3A4ALDH1A1MEN1CASP1KMT2A | |
| SCHEMBL30344840 | 0.81 | CYP3A4 (0.52) | CYP3A4ALDH1A1PDE10AMEN1CASP1 | |
| SCHEMBL1543342 | 0.81 | CYP3A4 (0.52) | CYP3A4ALDH1A1PDE10AMEN1CASP1 | |
| SCHEMBL30176806 | 0.80 | PDE10A (0.52) | CYP3A4ALDH1A1PDE10AMEN1CASP1 | |
| SCHEMBL621782 | 0.80 | ALDH1A1 (0.44) | CYP3A4ALDH1A1MEN1CASP1CASP7 | |
| SCHEMBL29831778 | 0.78 | RAB9A (0.59) | CYP3A4ALDH1A1PDE10AMEN1CASP1 | |
| SCHEMBL619653 | 0.78 | RAB9A (0.59) | CYP3A4ALDH1A1PDE10AMEN1CASP1 | |
| SCHEMBL1395608 | 0.77 | CA2 (0.66) | ALDH1A1MEN1KMT2ACYP1A2HTT | |
| SCHEMBL17394558 | 0.77 | CYP3A4 (0.62) | CYP3A4ALDH1A1PDE10AMEN1CASP1 | |
| Benzene SCHEMBL27716393 | 0.76 | CYP3A4 (0.61) | CYP3A4ALDH1A1PDE10AMEN1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6818777-B2 | AN INDOLE DERIVATIVES AS INTERMEDIATE FOR THE SYNTHESIS OF VINDOLINE, IS FORMED FROM A SUBSTITUTED ANILINE; SYNTHETIC EFFICIENCY, NONTOXIC REAGENTS | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2004-11-16 | — | — | US | disclosed |
| US-20040034217-A1 | Intermediates for synthesis of vinblastine compound and method for synthesizing the intermediate | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2004-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040034217-A1 | Intermediates for synthesis of vinblastine compound and method for synthesizing the intermediate | TOP2B, CCNB1, CCNB2 | CYP3A4 83/4885ALDH1A1 834/4885PDE10A 1316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.